Scarica l'app Stockscreener
5.47
4.20%
-0.24
Dopo l'orario di chiusura:
5.48
0.01
+0.18%
Precedente Chiudi:
$5.71
Aprire:
$5.63
Volume 24 ore:
4.90M
Relative Volume:
1.17
Capitalizzazione di mercato:
$535.99M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+2.24%
1M Prestazione:
+8.96%
6M Prestazione:
+80.53%
1 anno Prestazione:
+209.04%
Intervallo 1D:
$5.2303
$5.82
Intervallo di 1 settimana:
$5.165
$6.08
Portata 52W:
$1.67
$7.2904
Atyr Pharma Inc Stock (ATYR) Company Profile
Nome
Atyr Pharma Inc
Settore
Industria
Telefono
(858) 731-8389
Indirizzo
10240 SORRENTO VALLEY ROAD, SAN DIEGO
Confronta ATYR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATYR
Atyr Pharma Inc
|
5.47 | 553.62M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-18 | Iniziato | Leerink Partners | Outperform |
| 2025-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-10-04 | Iniziato | Wells Fargo | Overweight |
| 2024-09-05 | Iniziato | Jefferies | Buy |
| 2023-07-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-10-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-09-21 | Iniziato | Piper Sandler | Overweight |
| 2021-05-10 | Iniziato | Laidlaw | Buy |
| 2020-08-17 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | Iniziato | ROTH Capital | Buy |
| 2020-03-02 | Iniziato | Oppenheimer | Outperform |
| 2018-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-09-07 | Iniziato | Piper Jaffray | Overweight |
| 2016-12-13 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-12-16 | Iniziato | Citigroup | Neutral |
| 2015-06-01 | Iniziato | Citigroup | Buy |
| 2015-06-01 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Atyr Pharma Inc Borsa (ATYR) Ultime notizie
Is aTyr Pharma Inc. exposed to political riskMarket Risk Report & Daily Growth Stock Investment Tips - khodrobank.com
Tick level data insight on aTyr Pharma Inc. volatilityJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
aTyr Pharma Inc. recovery potential after sell off2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
Multi factor analysis applied to aTyr Pharma Inc.2025 Short Interest & Community Consensus Picks - Newser
Bank Watch: Is aTyr Pharma Inc. stock heavily shortedJuly 2025 Setups & Real-Time Volume Analysis Alerts - khodrobank.com
Risk adjusted return profile for aTyr Pharma Inc. analyzed2025 Analyst Calls & Entry Point Strategy Guides - Newser
Is aTyr Pharma Inc. a play on infrastructure spendingQuarterly Trade Review & Low Risk Growth Stock Ideas - khodrobank.com
Multi asset correlation models including aTyr Pharma Inc.Dividend Hike & Expert-Curated Trade Recommendations - Newser
Using AI based signals to follow aTyr Pharma Inc.July 2025 Chart Watch & Low Drawdown Investment Ideas - Newser
Top chart patterns to watch in aTyr Pharma Inc.Trade Performance Summary & Low Risk Investment Opportunities - Newser
How to build a custom watchlist for aTyr Pharma Inc.Wall Street Watch & Low Drawdown Investment Ideas - Newser
aTyr Pharma Inc.’s volatility index tracking explainedForecast Cut & Fast Exit/Entry Strategy Plans - Newser
Regression analysis insights on aTyr Pharma Inc. performanceM&A Rumor & High Accuracy Swing Trade Signals - Newser
Developing predictive dashboards with aTyr Pharma Inc. dataTrade Exit Summary & Verified Chart Pattern Trade Signals - Newser
When is the best time to exit aTyr Pharma Inc.Weekly Trend Report & Verified Short-Term Trading Plans - Newser
Is aTyr Pharma Inc. stock forming a triangle patternEarnings Performance Report & Technical Pattern Based Signals - khodrobank.com
Risk Hedge: Is aTyr Pharma Inc. stock heavily shortedWall Street Watch & Smart Allocation Stock Tips - khodrobank.com
Volatility clustering patterns for aTyr Pharma Inc.Portfolio Risk Summary & Technical Pattern Based Buy Signals - Newser
How to track smart money flows in aTyr Pharma Inc.2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
Price momentum metrics for aTyr Pharma Inc. explainedJuly 2025 Recap & Expert Curated Trade Ideas - Newser
What’s the analyst consensus on aTyr Pharma Inc.Weekly Profit Report & Risk Controlled Swing Alerts - khodrobank.com
Technical analysis overview for aTyr Pharma Inc. stockJuly 2025 Institutional & High Accuracy Buy Signal Tips - Newser
Can aTyr Pharma Inc. grow without external fundingJuly 2025 Momentum & Breakout Confirmation Trade Signals - khodrobank.com
Will breakout in aTyr Pharma Inc. lead to full recoveryMarket Performance Summary & Accurate Intraday Trading Signals - Newser
What is aTyr Pharma Inc.’s book value per shareJuly 2025 PostEarnings & AI Enhanced Trading Alerts - khodrobank.com
aTyr Pharma Inc. stock daily chart insightsPortfolio Performance Summary & Expert Verified Movement Alerts - Newser
Visualizing aTyr Pharma Inc. stock with heatmapsM&A Rumor & Community Trade Idea Sharing Platform - Newser
What is the Moat Score of aTyr Pharma Inc.2025 Key Highlights & Smart Swing Trading Techniques - khodrobank.com
Full technical analysis of aTyr Pharma Inc. stockEarnings Risk Report & Consistent Profit Focused Trading Strategies - Newser
What data driven models say about aTyr Pharma Inc.’s future2025 Market WrapUp & Community Trade Idea Sharing - Newser
Is it too late to sell aTyr Pharma Inc.July 2025 Patterns & Intraday High Probability Setup Alerts - Newser
What institutional flow reveals about aTyr Pharma Inc.Earnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
Using economic indicators to assess aTyr Pharma Inc. potentialWeekly Gains Report & Fast Exit Strategy with Risk Control - Newser
Earnings visualization tools for aTyr Pharma Inc.Stock Surge & Stock Portfolio Risk Control - Newser
Heatmap analysis for aTyr Pharma Inc. and competitorsWeekly Market Summary & Target Return Focused Stock Picks - Newser
Is aTyr Pharma Inc. stock bottoming outWeekly Trade Summary & Technical Pattern Based Signals - Newser
Can volume confirm reversal in aTyr Pharma Inc.Buy Signal & Fast Gain Swing Alerts - Newser
Cantor Fitzgerald Initiates Coverage of aTyr Pharma (ATYR) with Overweight Recommendation - MSN
Atyr Pharma Inc Azioni (ATYR) Dati Finanziari
Non sono disponibili dati finanziari per Atyr Pharma Inc (ATYR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Atyr Pharma Inc Azioni (ATYR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Broadfoot Jill Marie | Chief Financial Officer |
Feb 04 '25 |
Sale |
3.78 |
1,254 |
4,740 |
31,763 |
| DENYES NANCY | General Counsel |
Feb 04 '25 |
Sale |
3.78 |
899 |
3,398 |
26,555 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):